Global Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

According to APO Research, The global Transdermal Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Transdermal Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Transdermal Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal and IBSA Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transdermal Patch, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Transdermal Patch, also provides the sales of main regions and countries. Of the upcoming market potential for Transdermal Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Patch sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transdermal Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transdermal Patch sales, projected growth trends, production technology, application and end-user industry.

Transdermal Patch Segment by Company

Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Transdermal Patch Segment by Type

Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Transdermal Patch Segment by Application

Rx Channel
OTC Channel

Transdermal Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Transdermal Patch Market Size, 2020 VS 2024 VS 2031
1.3 Global Transdermal Patch Market Size Estimates and Forecasts (2020-2031)
1.4 Global Transdermal Patch Sales Estimates and Forecasts (2020-2031)
1.5 Global Transdermal Patch Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Transdermal Patch Market Dynamics
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 Transdermal Patch Market by Manufacturers
3.1 Global Transdermal Patch Revenue by Manufacturers (2020-2025)
3.2 Global Transdermal Patch Sales by Manufacturers (2020-2025)
3.3 Global Transdermal Patch Average Sales Price by Manufacturers (2020-2025)
3.4 Global Transdermal Patch Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Transdermal Patch Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Transdermal Patch Manufacturers, Product Type & Application
3.7 Global Transdermal Patch Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transdermal Patch Players Market Share by Revenue in 2024
3.8.3 2024 Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Transdermal Patch Market by Type
4.1 Transdermal Patch Type Introduction
4.1.1 Methyl Salicylate-based Patch
4.1.2 Rivastigmine Transdermal Patch
4.1.3 Fentanyl Transdermal Patch
4.1.4 Lidocaine Patch
4.1.5 Diclofenac Patch
4.1.6 Nicotine Transdermal Patch
4.1.7 Others
4.2 Global Transdermal Patch Sales by Type
4.2.1 Global Transdermal Patch Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Transdermal Patch Sales by Type (2020-2031)
4.2.3 Global Transdermal Patch Sales Market Share by Type (2020-2031)
4.3 Global Transdermal Patch Revenue by Type
4.3.1 Global Transdermal Patch Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Transdermal Patch Revenue by Type (2020-2031)
4.3.3 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
5 Transdermal Patch Market by Application
5.1 Transdermal Patch Application Introduction
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Patch Sales by Application
5.2.1 Global Transdermal Patch Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Transdermal Patch Sales by Application (2020-2031)
5.2.3 Global Transdermal Patch Sales Market Share by Application (2020-2031)
5.3 Global Transdermal Patch Revenue by Application
5.3.1 Global Transdermal Patch Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Transdermal Patch Revenue by Application (2020-2031)
5.3.3 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
6 Global Transdermal Patch Sales by Region
6.1 Global Transdermal Patch Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Transdermal Patch Sales by Region (2020-2031)
6.2.1 Global Transdermal Patch Sales by Region (2020-2025)
6.2.2 Global Transdermal Patch Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Transdermal Patch Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Transdermal Patch Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Transdermal Patch Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Transdermal Patch Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Transdermal Patch Revenue by Region
7.1 Global Transdermal Patch Revenue by Region
7.1.1 Global Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Transdermal Patch Revenue by Region (2020-2025)
7.1.3 Global Transdermal Patch Revenue by Region (2026-2031)
7.1.4 Global Transdermal Patch Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Transdermal Patch Revenue (2020-2031)
7.2.2 North America Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Transdermal Patch Revenue (2020-2031)
7.3.2 Europe Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Transdermal Patch Revenue (2020-2031)
7.4.2 Asia-Pacific Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Transdermal Patch Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Transdermal Patch Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Hisamitsu Pharmaceutical
8.1.1 Hisamitsu Pharmaceutical Comapny Information
8.1.2 Hisamitsu Pharmaceutical Business Overview
8.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
8.1.5 Hisamitsu Pharmaceutical Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Novartis Transdermal Patch Product Portfolio
8.3.5 Novartis Recent Developments
8.4 UCB Pharma
8.4.1 UCB Pharma Comapny Information
8.4.2 UCB Pharma Business Overview
8.4.3 UCB Pharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 UCB Pharma Transdermal Patch Product Portfolio
8.4.5 UCB Pharma Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Mylan Transdermal Patch Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Teva Pharmaceutical
8.6.1 Teva Pharmaceutical Comapny Information
8.6.2 Teva Pharmaceutical Business Overview
8.6.3 Teva Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
8.6.5 Teva Pharmaceutical Recent Developments
8.7 Nitto Denko
8.7.1 Nitto Denko Comapny Information
8.7.2 Nitto Denko Business Overview
8.7.3 Nitto Denko Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Nitto Denko Transdermal Patch Product Portfolio
8.7.5 Nitto Denko Recent Developments
8.8 Grünenthal
8.8.1 Grünenthal Comapny Information
8.8.2 Grünenthal Business Overview
8.8.3 Grünenthal Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Grünenthal Transdermal Patch Product Portfolio
8.8.5 Grünenthal Recent Developments
8.9 IBSA Group
8.9.1 IBSA Group Comapny Information
8.9.2 IBSA Group Business Overview
8.9.3 IBSA Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 IBSA Group Transdermal Patch Product Portfolio
8.9.5 IBSA Group Recent Developments
8.10 GSK
8.10.1 GSK Comapny Information
8.10.2 GSK Business Overview
8.10.3 GSK Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 GSK Transdermal Patch Product Portfolio
8.10.5 GSK Recent Developments
8.11 Luye Pharma Group
8.11.1 Luye Pharma Group Comapny Information
8.11.2 Luye Pharma Group Business Overview
8.11.3 Luye Pharma Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
8.11.5 Luye Pharma Group Recent Developments
8.12 Pfizer
8.12.1 Pfizer Comapny Information
8.12.2 Pfizer Business Overview
8.12.3 Pfizer Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Pfizer Transdermal Patch Product Portfolio
8.12.5 Pfizer Recent Developments
8.13 Chattem
8.13.1 Chattem Comapny Information
8.13.2 Chattem Business Overview
8.13.3 Chattem Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Chattem Transdermal Patch Product Portfolio
8.13.5 Chattem Recent Developments
8.14 Dr Reddy’s Laboratories
8.14.1 Dr Reddy’s Laboratories Comapny Information
8.14.2 Dr Reddy’s Laboratories Business Overview
8.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
8.14.5 Dr Reddy’s Laboratories Recent Developments
8.15 Bayer
8.15.1 Bayer Comapny Information
8.15.2 Bayer Business Overview
8.15.3 Bayer Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Bayer Transdermal Patch Product Portfolio
8.15.5 Bayer Recent Developments
8.16 Mundipharma
8.16.1 Mundipharma Comapny Information
8.16.2 Mundipharma Business Overview
8.16.3 Mundipharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Mundipharma Transdermal Patch Product Portfolio
8.16.5 Mundipharma Recent Developments
8.17 Endo International
8.17.1 Endo International Comapny Information
8.17.2 Endo International Business Overview
8.17.3 Endo International Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Endo International Transdermal Patch Product Portfolio
8.17.5 Endo International Recent Developments
8.18 Beijing Tide Pharmaceutical
8.18.1 Beijing Tide Pharmaceutical Comapny Information
8.18.2 Beijing Tide Pharmaceutical Business Overview
8.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Transdermal Patch Value Chain Analysis
9.1.1 Transdermal Patch Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Transdermal Patch Production Mode & Process
9.2 Transdermal Patch Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Transdermal Patch Distributors
9.2.3 Transdermal Patch Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings